Skip to content

A genetic counseling model combined with mindfulness therapy on anxiety and quality of life in breast cancer patients undergoing BRCA1 BRCA2 gene testing

A genetic counseling model combined with mindfulness therapy on anxiety and quality of life in breast cancer patients undergoing BRCA1 BRCA2 gene testing.

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260711002
Enrollment
50
Registered
2026-07-11
Start date
2026-01-15
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer patients referred by a physician for BRCA1 or BRCA2 gene mutation testing. Genetic counseling Mindfulness therapy Anxiety Quality of life BRCA1 and BRCA2 gene testing.

Interventions

5-day mindfulness therapy program. Day 1 Building Rapport and Education The initial 30-minute session focuses on welcoming breast cancer patients who have undergone gene testing. The researcher build
Experimental Behavioral,No Intervention No treatment
Genetic counseling model combined with mindfulness therapy,Usual care

Sponsors

Chonburi Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Breast cancer patients referred by a physician for BRCA1 or BRCA2 gene mutation testing. 2. age 20 year above 2. Able to communicate well, read Thai, and have no hearing problems. 3. Fully conscious and aware of the time, place, and people as usual. 4. Have a clear address and contact telephone number.

Exclusion criteria

Exclusion criteria: 1. Not participating in all activities. 2. Changing residence or treatment location. 3. Having complications from treatment requiring special medical care.

Design outcomes

Primary

MeasureTime frame
Anxiety 4 weeks, 8 weeks after intervention. The State-Trait Anxiety Inventory (STAI Form) ,Quality of life. 4 weeks, 8 weeks after intervention. The functional assessment of cancer therapy - breast cancer

Secondary

MeasureTime frame
Quality of life 4 weeks, 8 weeks after intervention. The functional assessment of cancer therapy - breast cancer

Countries

Thailand

Contacts

Public ContactPichayapa Pichaya

Chonburi Cancer Hospital

mampich3149@gmail.com0817823236

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026